Nomura Holdings
VNDA icon

Nomura Holdings’s Vanda Pharmaceuticals VNDA Stock Holding History

Nomura Holdings’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,487
Closed -$152K – 2188
2025
Q3 		$152K Sell
30,487
-9,584
-24% -$44.4K ﹤0.01% 1796
2025
Q2 		$189K Sell
40,071
-169
-0.4% -$739 ﹤0.01% 1306
2025
Q1 		$185K Buy
40,240
+127
+0.3% +$592 ﹤0.01% 1666
2024
Q4 		$192K Buy
40,113
+15
+0% +$72 ﹤0.01% 2057
2024
Q3 		$188K Buy
+40,098
New +$215K ﹤0.01% 1404

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

Nomura Holdings's VNDA Position: Q4 2025 in Review

Nomura Holdings sold out of Vanda Pharmaceuticals (VNDA) in Q4 2025, closing a stake of 30,487 shares — an estimated $152K sold.

Nomura Holdings first reported a position in VNDA in Q3 2024 and held it in 5 quarters. The position peaked at $192K in Q4 2024. 153 funds tracked by Wall St. Rank hold VNDA as of Q4 2025.

  • Nomura Holdings reported no remaining Vanda Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Nomura Holdings sold 30,487 Vanda Pharmaceuticals shares in Q4 2025, an estimated $152K.
  • Nomura Holdings first reported a position in Vanda Pharmaceuticals in Q3 2024 and held it in 5 quarters.
  • Nomura Holdings's Vanda Pharmaceuticals position peaked at $192K in Q4 2024.
  • 153 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2025.

Based on Nomura Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.